Samarasinghe Amali E, Randell Scott H, Kulkarni Hrishikesh S, Weiser Jeffrey N, Quinton Lee J, Dickson Robert P, Mizgerd Joseph P, Orihuela Carlos J, Parker Dane, Robinson Keven M, Prince Alice S, Evans Scott E, Kolls Jay K, Lee Janet S, Jeyaseelan Samithamby, Torres Antoni, Miller Lisa A, Hamilton David J, Gómez Marisa I, Moore Bethany B, Walker Rebecca L, Barkal Layla J, Hook Jaime L, Lau Gee W, Sharma Jyotika, Witzenrath Martin, Dela Cruz Charles S
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.
The global incidence of respiratory infectious diseases caused by bacteria continues to increase, with acute lower respiratory tract infections contributing to significant morbidity and mortality. Preclinical models designed to investigate such respiratory bacterial diseases are of utmost importance to decipher their pathogenesis and develop novel targets for intervention and treatment. Animal models offer the powerful ability to investigate different pneumonia types at varying stages of infection and disease. However, the same models can promote important variations in outcome, potentially confounding scientific understanding in the field. Therefore, an expert panel was convened to deliberate best practices in animal models of bacterial pneumonia to identify validated methodologies and acknowledge limitations in the use of animal and non-animal models in this field of study. Herein, we summarize this American Thoracic Society workshop on animal models of bacterial pneumonia. This workshop further includes review of non-animal complementary or alternative models for studying bacterial pneumonia. Emphasis was placed on discussion of bacterial pathogens that frequently cause community- and hospital-acquired pneumonia, highlighting key aspects in modeling infection. Animal models discussed included small and large animals, based on their strengths. Finally and most importantly, the ethical considerations in the use of animal modeling for the study of bacterial lung infections was discussed. This workshop report is intended to provide insights to investigators in the field and may serve as a starting point for formal recommendations in the future.
由细菌引起的呼吸道传染病的全球发病率持续上升,急性下呼吸道感染导致了显著的发病率和死亡率。旨在研究此类呼吸道细菌性疾病的临床前模型对于解读其发病机制以及开发新的干预和治疗靶点至关重要。动物模型具备强大的能力,可用于研究感染和疾病不同阶段的各种肺炎类型。然而,相同的模型可能会导致结果出现重要差异,这有可能混淆该领域的科学认知。因此,召集了一个专家小组来研讨细菌性肺炎动物模型的最佳实践,以确定经过验证的方法,并认识到在该研究领域使用动物模型和非动物模型的局限性。在此,我们总结了美国胸科学会关于细菌性肺炎动物模型的此次研讨会。该研讨会还包括对用于研究细菌性肺炎的非动物补充或替代模型的综述。重点讨论了经常导致社区获得性肺炎和医院获得性肺炎的细菌病原体,突出了感染建模中的关键方面。基于其优势,所讨论的动物模型包括小型和大型动物。最后且最重要的是,讨论了在使用动物模型研究细菌性肺部感染时的伦理考量。本研讨会报告旨在为该领域的研究人员提供见解,并可能作为未来正式建议的起点。
Arch Ital Urol Androl. 2025-6-30
Alzheimers Dement. 2021-4
NIH Consens State Sci Statements. 2002
Cochrane Database Syst Rev. 2014-11-6
2025-1
Int J Mol Sci. 2024-3-1
FEMS Microbiol Rev. 2024-3-1